Successful Pre-Clinical Trial and Granting of Key Patent
Filed with ASX · · 1 page · English
Vectus Biosystems Limited on 6ix
Earlier from Vectus Biosystems
- Appendix 4C - Quarterly Report and Update
- Admission to Official List
- Scientific Paper on Accugen Technology
- Key Accugen Patent Granted in USA
Later from Vectus Biosystems
- Appendix 4C - Quarterly
- Chairmans Address to Shareholders
- CEOs Address to Shareholders
- Response to ASX Appendix 4C Query
- Half Year Report and Appendix 4D
Follow Vectus Biosystems into a list and get an email when it puts out news.
Follow Vectus Biosystems